A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.

Long-term oral β-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% in ...

'A key part of my approach to ageing is to keep working,' says Sir Muir Gray ...

Just 7% of HFrEF patients received quadruple therapy, and even in this group, the absolute risk of events at 1 year was high.

A newly discovered collection of neurons suggests the brain and heart communicate to trigger a neuroimmune response after a heart attack, which may pave the way for new therapies ...

Get cardiovascular heart diseases latest news, Article video and Photos on cardiovascular heart diseases Explore latest health updates, news, information from TheHealthSite.com ...

Newry woman Caoimhe Loughran had a pacemaker fitted at just 20 years old and shares how walking has become her therapy ...

(NAPSI)—An estimated 20 million Americans have some form of thyroid disease.1 During January, recognized as Thyroid Awareness ...

One large international study demonstrated that severe hypoxia during attempted intubation of critically ill patients occurs ...

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc ...

A new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout.

The experimental drug IC7Fc reduces artery-clogging fats and inflammation in mice, pointing to a potential new strategy for ...